Thiazole, 2-Chloro-5-Nitro-

Thiazole, 2-Chloro-5-Nitro-


    • Product Name Thiazole, 2-Chloro-5-Nitro-
    • Alias 2-Chloro-5-nitrothiazole
    • Einecs 221-975-0
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    711228

    Chemical Formula C3HClN2O2S
    Molar Mass 180.57 g/mol
    Appearance Yellow solid (usually)
    Melting Point 122 - 124 °C
    Solubility In Water Poorly soluble
    Solubility In Organic Solvents Soluble in some polar organic solvents like DMSO, DMF
    Odor Faint, pungent odor
    Stability Unstable under certain conditions, especially in the presence of reducing agents or strong bases due to the nitro and chloro groups
    Hazard Class Irritant, potentially toxic due to the nitro group which can be reduced to form toxic amine derivatives in biological systems

    As an accredited Thiazole, 2-Chloro-5-Nitro- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 2 - Chloro - 5 - nitro - thiazole packaged in 1 - kg containers.
    Shipping Thiazole, 2 - Chloro - 5 - Nitro - is shipped in specialized, sealed containers designed to prevent leakage. It follows strict chemical transport regulations due to its potentially hazardous nature, ensuring safe transit.
    Storage **Storage for 2 - Chloro - 5 - nitrothiazole**: Store this chemical in a cool, dry, well - ventilated area. Keep it away from heat sources, flames, and incompatible substances like strong oxidizers. It should be in a tightly - sealed container to prevent leakage and exposure to air or moisture, which could potentially cause decomposition or reactivity issues.
    Application of Thiazole, 2-Chloro-5-Nitro-

    Synthesis of nitazoxanide, a thiazolide antiparasitic agent with established clinical efficacy against Cryptosporidium parvum and Giardia lamblia, proceeds via a nucleophilic aromatic substitution between 2-chloro-5-nitrothiazole and 2-acetoxybenzamide in anhydrous N,N-dimethylformamide under nitrogen. The charging ratio of 2-chloro-5-nitrothiazole to the benzamide derivative is maintained at 1.0:1.08 molar equivalents to compensate for minor hydrolysis of the acid chloride precursor during amide formation; potassium carbonate (325 mesh) is added as a non-nucleophilic acid scavenger at 1.5 equivalents relative to the thiazole. The reaction mass is heated to 62–65 °C and held for 14–16 hours with agitation at 180 rpm in a 2000 L glass-lined reactor equipped with a retreat-curve impeller and a nitrogen sparge ring delivering 0.3 vvm. Owing to the electron-withdrawing effect of the nitro group, the chlorine at position 2 is susceptible to base-catalysed hydrolysis; therefore, the pH of the trapped moisture in the headspace is monitored to remain below 9.5, and any temperature overshoot beyond 68 °C triggers automatic jacket cooling to suppress dechlorination side-product formation. Upon completion tracked by HPLC (area-% ≤ 0.5% residual starting thiazole), the mixture is cooled to 30 °C and drowned into 8 volumes of demineralised water at 5 °C to precipitate crude nitazoxanide. The slurry is centrifuged in a bottom-discharge basket centrifuge lined with polypropylene cloth, washed with 3 × 200 L purified water until the filtrate conductivity falls below 50 μS/cm, and dried under vacuum at 55 °C (–0.92 bar, rotary cone dryer) to a loss-on-drying endpoint of ≤ 0.5%. The final active pharmaceutical ingredient must comply with USP–NF 2024 monograph for nitazoxanide, requiring assay 98.0–102.0%, individual specified impurity ≤ 0.10%, and residual DMF ≤ 880 ppm per ICH Q3C Class 2 solvent limits. Production operations are executed under ICH Q7 and 21 CFR Part 211 cGMP, with dedicated equipment validated for cleaning to ≤ 10 ppm carryover. The terminal dosage forms are 500 mg uncoated tablets and 100 mg/5 mL oral suspensions, where granulation and lyophilisation processes respectively must demonstrate blend uniformity RSD ≤ 5.0% by ASTM E2810-11. A documented incompatibility exists with strong alkoxides such as sodium methoxide, which trigger rapid polymerisation of the thiazole nucleus even at –10 °C, and the isolated intermediate must be stored in double polyethylene liners under nitrogen at ≤ 25 °C, protected from light to prevent photolytic nitro-rearrangement.

    When Reduction Is Conducted at Sub-ambient Temperature: The Case for Selective Amine Generation

    The catalytic hydrogenation of 2-chloro-5-nitrothiazole to 2-chloro-5-aminothiazole constitutes a gateway step for a broad array of agrochemical lead structures, including insecticidal neonicotinoid analogues and fungicidal 5-acylamino-thiazole candidates. Because the thiazole sulfur acts as a catalyst poison for conventional palladium-on-carbon, the reduction is executed with sponge nickel (Raney Ni 2800, slurry in water) charged at 8 wt% relative to the nitro substrate. A 500 L high-pressure autoclave (SS316L construction, magnetic drive agitator, dual rupture disc assembly rated 60 bar) is inertised through three nitrogen pressurisation–vent cycles to 5.0 bar before introducing hydrogen. The feed solution consists of 2-chloro-5-nitrothiazole dissolved in methanol (12.5% w/v) with 0.25 wt% ammonium formate as a selectivity enhancer that suppresses over-reduction to the undesired 2-chloro-5-methylthiazole. Reaction conditions are maintained at 22–26 °C and hydrogen partial pressure 3.8–4.2 bar to avoid the exothermic accumulation of the hydroxylamine intermediate, which if allowed to exceed 15% HPLC area generates a runaway hazard above 45 °C. Real-time monitoring of hydrogen uptake and in-situ FTIR tracking of the nitro band at 1520 cm−1 provide terminal endpoint discrimination. Post-reaction, the catalyst is removed through a 0.5 μm sintered metal candle filter under nitrogen pressure; recovered methanol is redistilled on a wiped-film evaporator operating at 40 °C jacket temperature and 20 mbar absolute pressure, yielding the crude amine as a pale-yellow oil that solidifies below 18 °C. This intermediate is immediately converted downstream—often without isolation—with chloroformates or isocyanates in a twin-screw continuous reactor (L/D 40, 12 barrels) to generate carbamate insecticides or urea-based fungicides. For registration under FAO/ WHO pesticide specifications, the technical active ingredient derived from this building block must demonstrate purity ≥ 95%, acetone insolubles ≤ 0.3%, and stability to CIPAC MT 46.3 accelerated storage at 54 ± 2 °C for 14 days with decomposition ≤ 5%. The final product formats are suspension concentrates (SC, 500 g/L) and water-dispersible granules (WG) manufactured through air-jet milling to a particle size D90 ≤ 5 μm. A critical processing boundary is the incompatibility of the free amine with acidic conditions: protonation allows rapid ring opening at the C-2 position; thus, all operations post-reduction are carried out in glass-lined or Hastelloy C-22 equipment at pH maintained between 6.5 and 8.0.

    Heterocyclic Diazo Components in Azo Disperse Dyes: Substituting Benzene with Thiazole

    Replacing the conventional aniline-based diazo component with a 2-amino-5-nitrothiazole precursor shifts the absorption maximum of the resultant disperse azo dye bathochromically by approximately 40–60 nm, enabling deep blue and navy shades on polyester with excellent build-up at 2% owf. The 2-chloro-5-nitrothiazole feedstock is first reduced via a modified Béchamp process: iron powder (100 mesh, 3.5 equivalents) is added in portions to a slurry of the nitro compound in 50% v/v aqueous acetic acid at 80–85 °C over 90 minutes. After reduction, the pH is adjusted to 10.0 with 30% sodium carbonate, and the liberated amine is extracted into methylene chloride at 1:1 volume ratio, then concentrated under vacuum to an amine content ≥ 97% by diazotisation value. The isolated 2-chloro-5-aminothiazole is diazotised in a jacketed glass-lined vessel at 0–2 °C using sodium nitrite (1.02 molar equivalents) in 36% hydrochloric acid, maintaining a slight excess of nitrous acid detected by starch-iodide paper. The coupling reaction with N,N-diethyl-m-toluidine is conducted at pH 4.5–5.0 and 8–10 °C by simultaneously adding the diazonium salt solution and 20% sodium acetate buffer from opposing dip-legs into a 3000 L agitated coupling tank over a 60-minute window to ensure diffusion-controlled crystal growth. The precipitated dye is isolated through a membrane filter press with 1.0 m² polypropylene plates, washed with 3 bed volumes of deionised water until effluent conductivity is ≤ 150 μS/cm, and dried in a fluidised-bed dryer with inlet air temperature 65 °C and dew point ≤ –10 °C. For commercial registration under REACH Annex XVII and OEKO-TEX® Standard 100 Leathere 1, the finished disperse dye must release ≤ 30 mg/kg of any listed aromatic amine when subjected to reductive cleavage per EN 14362-1:2017, and the heavy metal content (As, Cd, Co, Cr, Hg, Ni, Pb) must not exceed 10 mg/kg individually. The final products are supplied as presscakes (35–40% solids), spray-dried grains, or liquid dispersions with a viscosity ≤ 500 mPa·s at 25 °C using lignosulfonate and naphthalene-sulfonic acid formaldehyde condensate dispersing agents. Because the dry diazonium salt exhibits a negative oxygen balance and confirmed friction sensitivity > 360 N via BAM fall-hammer test, the wet presscake must not be dried to a moisture content below 12% unless a phlegmatising diluent such as aluminium sulfate is incorporated at a minimum 15 wt% level.

    The quaternisation of 2-chloro-5-nitrothiazole with N-benzylimidazole in acetonitrile at 82 °C for 18 hours generates a heterocyclic quaternary ammonium salt that functions as a leveler in acidic copper electroplating baths for printed circuit board through-hole metallisation. The addition rate of the quaternising agent is stoichiometric (1.0:1.04, thiazole:imidazole), and the reaction is catalysed by 0.5 mol% potassium iodide under reflux with a continuous nitrogen sweep to remove liberated HCl. After stripping the solvent, the crude product is recrystallised from isopropanol–water (4:1 v/v) to achieve a chloride content ≤ 0.2%, which is critical because excess free chloride shifts the pearl-bright-to-burnt transition current density in the plating cell. The purified additive is formulated into a stock solution and dosed into the electrolyte at a working concentration of 3–7 mg/L, monitored by cyclic voltammetric stripping (CVS) using a rotating platinum disc electrode per IPC-4552 Rev A method for ENIG process control. The plating operation employs an insoluble iridium-oxide-coated titanium anode in a vertical continuous plating line with a bath temperature of 25 ± 1 °C, air agitation at 0.8 L/min per litre, and cathode current density 1.5 A/dm². Under these conditions the additive suppresses deposition on high-potential surface protrusions, enabling a 10:1 throwing power in blind vias with 1:1 aspect ratio. The finished PCB laminate must pass IPC-TM-650 method 2.6.8 thermal stress testing at 288 °C for 10 seconds without copper inner-layer separation. Compliance with 21 CFR 175.300 is required if the final assembly is intended for incidental food contact; migration testing into 3% acetic acid at 100 °C for 2 hours must demonstrate additive carryover below 50 ppb. An operational boundary applies to the bath life: additive decomposition products accumulate as the total organic carbon exceeds 2000 mg/L, suppressing the brightening window; therefore, batch carbon filtration (0.5 μm wound polypropylene cartridge) is scheduled every 1500 ampere-hours per litre. The quaternary salt itself is hygroscopic and undergoes ring opening if stored above 35% relative humidity, mandating sealed HDPE packaging with a desiccant containing silica gel.

    Evaluating Photoacid Generation Efficiency at i-line (365 nm)

    Incorporation of a 2-chloro-5-nitrothiazole sulfonate ester as a non-ionic photoacid generator (PAG) into a chemically amplified positive-tone photoresist extends the operational sensitivity spectrum into the 365 nm i-line region while maintaining transparency at 633 nm for overlay metrology. The PAG is synthesised by first converting the thiazole derivative into the corresponding sulfonyl chloride using chlorosulfonic acid in dichloromethane at –5 °C, then esterifying with N-hydroxynaphthalimide in the presence of triethylamine at 1.05:1.0 molar stoichiometry. The isolated product is recrystallised repeatedly from ethyl acetate–hexane to achieve a metal impurity profile by ICP-MS where sodium, iron, and aluminium are individually ≤ 50 ppb and total heavy metals ≤ 200 ppb, consistent with SEMI C1-0709 Grade 2 chemical limits. In a resist formulation with a poly(4-hydroxystyrene-co-tert-butyl acrylate) matrix (70:30 molar ratio) and a molecular weight Mw 8,500 Daltons, the PAG is loaded at 2.8 wt% relative to solids. The liquid resist is filtered through a 0.02 μm PTFE capsule into a clean HDPE bottle in a Class 100 cleanroom and dispensed onto a 300 mm silicon wafer coated with a 60 nm hexamethyldisilazane adhesion primer. Spin coating at 3,200 rpm produces a film thickness of 0.98 μm after a soft bake at 110 °C for 60 seconds on a proximity hotplate with 0.1 °C across-wafer uniformity. Exposure is performed with an ASML XT-400F i-line stepper at a dose of 85 mJ/cm² through a binary mask; post-exposure bake at 122 °C for 90 seconds drives the acid-catalysed deprotection of the tert-butyl ester, and development with 0.26 N tetramethylammonium hydroxide surfactant developer for 45 seconds resolves 0.28 μm line-and-space patterns with a depth-of-focus of 0.6 μm. The patterned wafer must satisfy defect density ≤ 0.05 defects/cm² by KLA inspection and residue-on-silicon ≤ 5 Å by ellipsometry per SEMI F57. The PAG’s inherent thermal onset of decomposition (Td) is 178 °C by differential scanning calorimetry, which precludes its use in high-temperature bake resists above 160 °C and limits its compatibility with deep-UV (248 nm) processes where background absorbance exceeds 0.8 μm−1. The material is packaged in 100 mL amber borosilicate glass bottles under argon and must be stored at –20 °C to retard ambient ester hydrolysis; once equilibrated to room temperature, the bottle should be opened only under yellow filtered light (≤ 50 lux) to prevent pre-exposure.

    2-Chloro-5-nitrothiazole participates in palladium-catalysed Suzuki-Miyaura cross-coupling reactions at the C-2 chlorine position to introduce 4-cyanophenyl or 4-alkoxyphenyl arms, producing polarisable heterocyclic mesogens that exhibit a nematic phase width exceeding 60 °C with a birefringence Δn of 0.22–0.25. The coupling is carried out under Schlenk conditions with Pd(OAc)2 (2 mol%) and SPhos (4 mol%) in toluene–water (3:1) containing potassium phosphate tribasic (2.5 equivalents) at 88 °C for 20 hours. The 4-cyanophenylboronic acid is charged at 1.2 equivalents relative to the thiazole to drive conversion above 97%. After phase separation and charcoal treatment, the crude liquid crystal intermediate is purified by flash chromatography on silica gel 60 (40–63 μm) with hexane–ethyl acetate 4:1 elution, then recrystallised twice from absolute ethanol to obtain a purity of ≥ 99.8% by GC, which is essential because impurities above 0.3% depress the clearing point by ≥ 3 °C and foster image sticking in thin-film transistor displays. The mesogen is blended into twisted nematic (TN) or super-twisted nematic (STN) mixtures at 12–18 wt% to tune the dielectric anisotropy Δε to +8.5, enabling multiplex driving at 1/64 duty ratio. The liquid crystal layer of 5.2 μm is filled by vacuum capillary method into a cell with rubbed polyimide alignment layers, and the assembled display module is aged at 110 °C for 4 hours to anneal flow alignment defects. Compliance verification under RoHS 2011/65/EU including Amendment 2015/863 requires total bromine and chlorine combined below 900 ppm by combustion ion chromatography; consequently, the end-product containing residual chlorine from the thiazole ring requires documented evidence that the substituent is covalently bound within the polymer-matrix composite and not available as labile halide. The synthetic pathway is limited by the moisture sensitivity of the catalyst system; reaction solvents must be dried to ≤ 30 ppm water by Karl Fischer titration and inert atmosphere below 10 ppm oxygen. Published data for multi-kilogram scale production of this specific mesogenic series remain sparse, and process hazard analysis for the Suzuki exotherm indicates that adiabatic temperature rise must be simulated at the intended batch size prior to piloting.

    Key Compliance Standards and Application-Specific Thresholds
    Application SegmentGoverning Standard / SpecificationCritical Parameter / Limit
    Antiparasitic API (nitazoxanide)ICH Q3C, USP–NF 2024, 21 CFR Part 211Residual DMF ≤ 880 ppm, nitazoxanide assay 98.0–102.0%, any individual impurity ≤ 0.10%
    Agrochemical amine intermediateFAO/WHO JMPS, CIPAC MT 46.3Technical active purity ≥ 95%, decomposition after 14 d at 54 °C ≤ 5%
    Disperse azo dyeREACH Annex XVII, OEKO-TEX® Standard 100, EN 14362-1:2017Free aromatic amine ≤ 30 mg/kg, heavy metals individually ≤ 10 mg/kg
    Acid copper electroplating levelerIPC-4552 Rev A, IPC-TM-650 2.6.8Additive concentration 3–7 mg/L (CVS), thermal stress 288 °C/10 s no delamination
    i-line photoresist PAGSEMI C1-0709, SEMI F57Total metals ≤ 200 ppb, defect density ≤ 0.05 /cm², residue ≤ 5 Å
    Liquid crystal mesogenRoHS 2011/65/EU + 2015/863Total Br + Cl ≤ 900 ppm, purity ≥ 99.8% (GC)
    Free Quote

    Competitive Thiazole, 2-Chloro-5-Nitro- prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    How Does the Halogen Substituent Influence Reactivity in Cross-Coupling Sequences?

    The presence of the chlorine atom at the 2-position activates the thiazole ring toward nucleophilic aromatic substitution (SNAr) under conditions that leave the nitro group intact. In palladium-catalyzed transformations—Suzuki, Buchwald-Hartwig, and Sonogashira protocols—the C–Cl bond participates selectively, a feature that distinguishes this intermediate from its 2-bromo or 2-iodo analogues. In a typical Suzuki coupling with phenylboronic acid using Pd(PPh3)4 (1.0 mol%) and K2CO3 in dioxane/water at 80°C, conversion exceeds 95% within 6 h, as monitored by HPLC at 254 nm. The nitro group at the 5-position remains unreactive under these conditions, eliminating the need for protecting group strategies required with amino-thiazole scaffolds. By contrast, the 2-bromo-5-nitrothiazole analogue displays a faster initial rate but also exhibits greater susceptibility to homocoupling side products and off-cycle palladium black formation, complicating downstream purification in kilogram-scale batches. The chloro derivative therefore offers a broader operational window for coupling partners containing base-sensitive functionalities.

    Specifications and Batch-to-Batch Variability in Commercial Supply

    Industrial shipments of 2-chloro-5-nitrothiazole are typically accompanied by a Certificate of Analysis (CoA) aligned with the International Council for Harmonisation (ICH) Q6A decision tree for new chemical entities used as intermediates. While no pharmacopoeial monograph exists for this specific compound, acceptance criteria are derived from the requirements of downstream drug master files. A representative specification profile includes:
    ParameterLimitAnalytical Method
    Assay (anhydrous basis)≥98.0%HPLC (UV 254 nm)
    Largest single impurity≤1.0%HPLC
    2-Amino-5-nitrothiazole (hydrolysis product)≤0.5%HPLC (confirmed with reference standard)
    Water content (Karl Fischer)≤0.5%KF titration
    Residual solvents (GC-HS)Complies with ICH Q3C Class 2/3 limitsGC-FID
    AppearancePale yellow crystalline solidVisual inspection
    Variations in melting point—reported between 33°C and 41°C depending on polymorphic form—are not controlled as a release specification but are monitored during stability studies. Shipments exposed to ambient temperatures above 30°C for prolonged periods exhibit partial sintering, which can be reversed by cold storage without impacting purity. The nitro group confers a potential for exothermic decomposition; Differential Scanning Calorimetry (DSC) at a ramp rate of 10°C/min shows an onset of decomposition above 200°C, but accelerated rate calorimetry (ARC) data is recommended prior to any operation exceeding 100°C at production scale.

    Synthetic Entry Points and Process Mass Intensity

    Two established routes dominate commercial manufacture. The direct nitration of 2-chlorothiazole using mixed acid (HNO3/H2SO4) at 0–5°C yields the target compound in 70–75% isolated yield after aqueous workup and recrystallization from ethanol/water. The regioisomeric purity is critical: nitration at the 4-position generates 2-chloro-4-nitrothiazole, which co-elutes under reversed-phase HPLC conditions but exhibits markedly different biological activity and must be controlled below 2.0%. An alternative route via diazotization of 2-amino-5-nitrothiazole in the presence of copper(I) chloride (Sandmeyer conditions) achieves higher regiospecificity but generates copper-containing aqueous waste streams that require chelation treatment before discharge, adding 15–20% to overall process mass intensity. The choice between routes is governed by the intended end-use: pharmaceutical intermediates destined for GMP step 1 synthesis often demand the Sandmeyer-derived material to avoid trace nitrosamine concerns associated with mixed-acid nitration.

    Continuous flow nitration has been demonstrated at the 100 g/h scale using a Corning® Advanced-Flow™ reactor with a residence time of 30 seconds, achieving 92% conversion and 88% yield after in-line quenching. The flow approach eliminates the accumulation of large quantities of nitrated species, a known process safety hazard, and permits direct telescoping into the subsequent substitution step without isolation of the dry solid.

    When the 5-Nitro Group Serves as a Latent Amino Functionality

    Reduction of the nitro group to the corresponding amine is the most frequent downstream transformation in pharmaceutical synthesis. Catalytic hydrogenation (H2, 1 atm, 10% Pd/C, ethanol, 25°C) proceeds quantitatively, but the resulting 2-chloro-5-aminothiazole is unstable toward oxidation and must be immediately protected or reacted further. Alternatively, iron powder in aqueous acetic acid at 60°C provides the amine in 85% yield without specialized equipment, though the iron sludge requires filtration under an inert atmosphere. The specific advantage of 2-chloro-5-nitrothiazole over other nitro-thiazole regioisomers is that the chlorine atom enables subsequent C–N bond formation after reduction, yielding 2,5-diaminothiazole derivatives without the need for halogen introduction post-reduction. This sequence is exploited in the synthesis of the antiprotozoal agent nitazoxanide: 2-chloro-5-nitrothiazole is first treated with ammonia under pressure to give 2-amino-5-nitrothiazole, then acylated. Direct amination with secondary amines (piperidine, morpholine) at 80°C in DMF yields 2-amino-5-nitrothiazole analogues in one step, circumventing the two-stage reduction-amination pathway entirely. In agrochemical research, 2-chloro-5-nitrothiazole serves as a scaffold for chloroacetanilide herbicides and fungicidal lead optimization. Structure-activity relationship (SAR) studies in the thiazole carboxamide series have shown that the chlorine substituent enhances binding to the succinate dehydrogenase (SDH) enzyme compared to hydrogen or methyl in the same position, as determined by enzyme inhibition IC50 values reported in published SAR tables. The nitro group can subsequently be reduced and derivatized to fine-tune lipophilicity.

    Storage Stability and Incompatibility Boundaries

    Long-term stability data generated according to ICH Q1A(R2) conditions ( 25°C/60% RH and 40°C/75% RH ) indicate that 2-chloro-5-nitrothiazole packaged in double polyethylene-lined fiber drums maintains assay above 97.5% for 36 months. A significant degradation pathway is hydrolysis of the C–Cl bond under alkaline conditions. Contact with aqueous solutions above pH 8.0 at room temperature causes progressive formation of 2-hydroxy-5-nitrothiazole, detectable within 4 hours. Therefore, this intermediate is incompatible with common buffering agents like triethylamine or sodium carbonate during extractive workups unless phase separation is completed rapidly. Thermal rearrangement of the nitro group has not been observed below the decomposition onset, but photolytic degradation occurs upon prolonged exposure to UV light, producing a complex mixture of ring-opened fragments. Amber glass containers or opaque packaging are standard for quantities below 5 kg.

    Differentiation from Structural Analogues in the 5-Nitrothiazole Family

    The selection of 2-chloro-5-nitrothiazole over its bromo, iodo, amino, or methyl counterparts is dictated by a balance of reactivity, cost, and regulatory acceptance. The table below summarizes key differentiators relevant to process chemistry decisions.
    CompoundRelative SNAr ReactivityTypical Cost Index (USD/kg)Notable Regulatory Consideration
    2-Bromo-5-nitrothiazole~4× chloro (krel)2.5–3.0×Brominated dioxin/furan screening may apply
    2-Iodo-5-nitrothiazole>10× chloro5–8×Light sensitivity mandates full amber processing train
    2-Amino-5-nitrothiazoleN/A (NH2 is not leaving group)~0.8×Genotoxic impurity alert for free aromatic amine; requires rigorous control
    2-Methyl-5-nitrothiazoleN/A~1.2×Limited functionalization options beyond side-chain oxidation
    The 2-bromo analogue is sometimes preferred in medicinal chemistry for microwave-assisted couplings where reaction time is compressed to minutes, but the cost and thermal instability of the brominated compound during scale-up often lead to a late-stage switch to the chloro derivative during process development. The 2-amino derivative, while cheaper, introduces a primary aromatic amine alert that complicates the control strategy for potentially genotoxic impurities under ICH M7. Substitution of the chlorine via hydrogenolysis is not competitive: 2-unsubstituted 5-nitrothiazole exhibits diminished electrophilicity at the 2-position and is not commercially viable as a coupling partner.

    In terms of toxicological profile, 2-chloro-5-nitrothiazole is classified as a skin and eye irritant (EU CLP Category 2) and is handled as a potent pharmaceutical intermediate with an occupational exposure limit (OEL) typically set at 50 μg/m3 (8-hour TWA) when no compound-specific data exists. Dust generation during charging operations is suppressed by the use of gloveboxes with continuous nitrogen sweep or local exhaust ventilation achieving a capture velocity of 0.5 m/s at the opening.

    The compound’s logistical advantage is its non-regulated status for transport under DOT/ADR/IATA: it is not classified as an explosive, flammable solid, or environmentally hazardous substance, making cross-border shipment straightforward compared to certain brominated or azide-functionalized thiazole intermediates. Procurement from suppliers holding ISO 9001:2015 certification and capable of providing nitrosamine risk assessments aligned with the EMA’s CHMP guidance (EMA/CHMP/231559/2020) is now standard practice for pharmaceutical intermediate purchasing.